1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
35.46%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
-171.55%
Negative gross profit growth while MAXN is at 73.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
-922.43%
Negative EBIT growth while MAXN is at 71.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-930.10%
Negative operating income growth while MAXN is at 66.50%. Joel Greenblatt would press for urgent turnaround measures.
-948.31%
Negative net income growth while MAXN stands at 73.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-946.15%
Negative EPS growth while MAXN is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-943.59%
Negative diluted EPS growth while MAXN is at 73.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share change of 0.00% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.07%
Diluted share change of 0.07% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
279.96%
OCF growth above 1.5x MAXN's 93.92%. David Dodd would confirm a clear edge in underlying cash generation.
19.65%
FCF growth under 50% of MAXN's 91.23%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
58.55%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-17.44%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-46.77%
Negative 3Y CAGR while MAXN stands at 7.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
23.68%
Positive long-term OCF/share growth while MAXN is negative. John Neff would see a structural advantage in sustained cash generation.
-71.13%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-63.14%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-6403.77%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-234.35%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-497.53%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-91.06%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-87.75%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-91.23%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.19%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-13.57%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-15.77%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-74.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-24.22%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.20%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.03%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.